Is a 7.4 A1C Bad? What the Number Really Means

A 7.4% A1C is above the 6.5% threshold that defines diabetes, but it falls within or very close to the target range that major medical guidelines recommend for most adults with type 2 diabetes. The American College of Physicians, for instance, recommends aiming for an A1C between 7% and 8% for most people.¹ Whether 7.4% is “bad” depends less on the number itself and more on who you are, how long you have had diabetes, what complications you already face, and what risks come with pushing that number lower.

What a 7.4% A1C Translates To in Daily Life

A1C measures the percentage of your hemoglobin that has glucose attached to it, reflecting your average blood sugar over roughly two to three months. Using the standard conversion formula, a 7.4% A1C corresponds to an estimated average glucose of around 166 mg/dL.² That means if you were checking your blood sugar at random points throughout the day and night, the readings would cluster around 166, sometimes higher after meals and sometimes lower overnight or between meals. For context, someone without diabetes typically has an average glucose closer to 100 mg/dL.

That gap matters, but the question is how urgently it needs to close and how far it needs to close. A person newly diagnosed at 40 and a person who has lived with diabetes for 25 years and is now 72 should not necessarily chase the same A1C number, as we will see below.

Where 7.4% Sits on the Official Scales

The diagnostic thresholds are straightforward. An A1C below 5.7% is considered normal. Between 5.7% and 6.4% is prediabetes. At 6.5% or above, you have diabetes.³ So 7.4% is clearly in the diabetes range. But diagnosis and treatment targets are two different things. Once you have diabetes, your doctor is not necessarily trying to get you all the way back below 6.5%. For most adults with type 2 diabetes on medication, the ACP guidance statement recommends a target between 7% and 8%.¹ By that yardstick, 7.4% is solidly in the middle of the recommended range.

The American Diabetes Association tends to recommend a somewhat tighter target of below 7% for many adults, while still acknowledging that less stringent goals are appropriate for certain people. This is a genuine area of disagreement among professional bodies: the ADA leans a bit more aggressive, the ACP a bit more relaxed. If your doctor has told you to aim for under 7%, then 7.4% means you are close but not quite there. If your target is 7 to 8%, you are right on track. Which target is right for you depends on factors that deserve their own discussion.

Why Your Target Might Be Different From Someone Else’s

The push to individualize A1C goals grew out of evidence that a single universal target does not serve everyone well. For younger people diagnosed relatively recently who do not yet have significant complications, near-normal A1C levels can help prevent problems from developing over the decades ahead.⁴ A 35-year-old with type 2 diabetes and no eye or kidney damage has a strong argument for aiming below 7%, because every year spent at higher glucose levels adds cumulative risk.

Older adults are a different story entirely. A person in their mid-70s with other health conditions, limited life expectancy, or cognitive decline faces diminishing returns from tight blood sugar control and increasing risk of harm from the treatment itself. The heterogeneity among older people with diabetes is enormous, and clinical guidelines consistently emphasize that treatment should account for someone’s overall health, existing complications, and how many years of life they are likely to benefit from tighter control.⁵ For a frail 80-year-old, an A1C of 7.4% might be perfectly appropriate, and pushing it lower could do more harm than good.

The same principle applies to people with a history of severe low blood sugar episodes, those with advanced heart disease, or anyone for whom the medications needed to bring A1C down carry meaningful side effects. The question is always about the balance between future benefit and present risk.

The Complications Picture at 7.4%

This is where many people get anxious, so it is worth being specific about what the research actually shows. In a large Swedish study of people with type 1 diabetes, those with A1C levels between 7.0% and 7.4% had modestly higher risks of retinopathy and early kidney damage compared to those in the 6.5 to 6.9% range.⁶ The risk was real but not dramatic. And these were people with type 1 diabetes, who tend to have had elevated blood sugar since childhood and face somewhat different risk profiles than those with type 2.

A meta-analysis of randomized controlled trials in people with type 2 diabetes found that achieving an A1C in the range of roughly 7.1% to 7.7% was associated with meaningful reductions in several complications compared to higher levels. The group in that range saw about a 46% reduction in retinopathy, a 52% reduction in significant kidney protein leakage, and a 36% reduction in non-fatal stroke compared to groups with higher A1C values.⁷ That same meta-analysis found a 22% reduction in death from any cause in the 7.1 to 7.7% group. So being at 7.4% appears to be in a range where you are already capturing a large share of the protective benefit compared to running significantly higher.

One wrinkle is cardiovascular risk. A study that stratified patients by their existing heart disease risk found that an A1C in the 7.0 to 8.0% range was associated with higher cardiovascular risk in people who already had moderate baseline risk factors, though not in those with lower risk.⁸ This underscores the point that your overall cardiovascular health shapes whether 7.4% should prompt more or less urgency. Someone with high blood pressure, high cholesterol, and a family history of heart attacks may need to think about 7.4% differently than someone whose only metabolic concern is glucose.

The Real Danger of Pushing Too Low

One of the most important findings in diabetes management over the past two decades came from the ACCORD trial, which tested whether aggressively lowering A1C below 6.0% in people with type 2 diabetes and high cardiovascular risk would reduce heart problems. It did not. Instead, the group receiving intensive treatment had more deaths than the group aiming for a standard target of 7 to 7.9%.⁹ The intensive-therapy arm was stopped early because of the excess mortality. Low blood sugar episodes requiring help from another person were far more common in the intensive group, as was significant weight gain.

The follow-up analysis, looking at outcomes five years out, confirmed the pattern: intensive therapy led to fewer non-fatal heart attacks but more deaths overall, driven largely by cardiovascular deaths.¹⁰ The conclusion was stark: targeting an A1C below 6% cannot be recommended for high-risk patients with advanced type 2 diabetes. This trial reshaped how doctors think about A1C goals and is a major reason why guidelines now give a range rather than a single number. If you are at 7.4% and wondering whether you should be at 6.0%, the ACCORD trial is the main reason your doctor might tell you not to push that hard.

The risks of overtreatment are not abstract. Severe hypoglycemia can cause confusion, falls, seizures, and heart rhythm disturbances. For older adults especially, a bad low blood sugar event can mean a broken hip or a car accident. A modest A1C benefit is not worth that trade-off when the starting point is already in a reasonable range.

When Your A1C Might Be Lying to You

A1C is treated as the gold standard for assessing glucose control, and for most people it does the job well. But there are situations where the number on your lab report does not accurately reflect your actual average blood sugar, and knowing about these can save you from either false reassurance or unnecessary alarm.

Iron deficiency anemia is a common one. In people without diabetes, iron deficiency anemia was associated with significantly higher A1C readings compared to people with normal blood counts. Once the iron deficiency was treated, A1C dropped meaningfully even though glucose levels had not changed.¹¹ Sickle cell anemia similarly inflated A1C values. If you have untreated iron deficiency, your 7.4% might actually represent blood sugar levels closer to what a 7.0% would show in someone with normal iron stores.

The opposite problem occurs in chronic kidney disease. In people with kidney failure, A1C tends to underestimate actual glucose levels by roughly 1.5 percentage points at critical treatment thresholds.¹² That is a huge discrepancy. If you have advanced kidney disease and your A1C reads 7.4%, your true average glucose may be much higher than the number suggests. A study using continuous glucose monitors confirmed this problem, finding that the gap between A1C and actual glucose readings was significantly larger in people with chronic kidney disease than in those without it.¹³

Other conditions that alter red blood cell lifespan can throw off A1C in either direction. Recent blood transfusions, hemolytic anemias, and certain hemoglobin variants all interfere. If your A1C seems inconsistent with what your home glucose meter or continuous monitor shows, one of these factors may be the explanation.

What A1C Cannot Tell You

Even when A1C is accurate, it has a blind spot: it gives you an average, but averages can hide wild swings. Two people can have the same 7.4% A1C, but one might have blood sugar that stays relatively stable in the 140 to 190 range, while the other ricochets between 50 and 300 throughout the day. The second person’s experience is far more dangerous and unpleasant, but the A1C does not distinguish between them. Researchers have argued that glycemic variability deserves more attention as an independent risk factor for complications.¹⁴

This is where a metric called “time in range” has become increasingly important. Time in range measures the percentage of the day your blood sugar stays between 70 and 180 mg/dL, and it correlates strongly with A1C. For every 10 percentage point change in time in range, A1C shifts by about 0.8%.¹⁵ But time in range also captures the information that A1C misses: how much of your day is spent dangerously low versus dangerously high. If you wear a continuous glucose monitor, your time in range data can give your doctor a much richer picture than A1C alone.

Continuous monitor data and A1C usually agree reasonably well. Studies in real-world conditions have confirmed a strong correlation between the two measurements.¹⁶ But when they disagree, the continuous monitor data tends to be more trustworthy for day-to-day management decisions, especially in the populations where A1C can be misleading.

Practical Ways to Move 7.4% Lower If That Is Your Goal

If you and your doctor have decided that getting below 7% would be worthwhile in your case, the good news is that several interventions can chip away at A1C, and they stack. The evidence supports a multi-pronged approach.

Diet changes tend to show the fastest results. A randomized trial found that a low-carbohydrate diet reduced A1C by about 0.23% more than a usual diet over six months.¹⁷ That might sound small, but when you are starting at 7.4% and trying to reach 7.0%, a quarter of a percentage point from diet alone gets you more than halfway there. A personalized program combining customized nutrition with progressive exercise produced an average A1C drop of nearly two full percentage points in one study, though participants in that study started at a much higher average of 9.0%.¹⁸

Exercise matters, though the type of exercise makes a difference. A trial testing aerobic exercise, resistance training, and a combination of both found that only the combination group achieved a statistically significant A1C reduction compared to controls, with an absolute drop of about 0.34%.¹⁹ Neither aerobic exercise alone nor resistance training alone reached statistical significance on its own, though both trended in the right direction. If you are choosing between the gym and walking, the answer from this trial is to do both.

When lifestyle changes are not enough, medications are effective. A systematic review and network meta-analysis of over 200 randomized trials found that all major drug classes for type 2 diabetes significantly reduced A1C when added to metformin, with average reductions ranging from about half a percentage point to just under one full point depending on the drug.²⁰ Insulin regimens and GLP-1 receptor agonists (drugs like semaglutide and liraglutide) tend to produce the largest reductions.²¹ Your doctor’s choice among these depends on your other health conditions, body weight, kidney function, heart disease risk, and what you can tolerate.

The Emotional Weight of a Number

Something that often gets lost in the clinical discussion is how it feels to be told your A1C is 7.4%. For many people, the number becomes a report card, and anything above the target feels like a personal failure. This reaction is understandable but worth examining, because the psychological burden of diabetes management is itself a health issue.

Research has shown that therapy focused only on managing blood sugar does not produce the best health outcomes. Factors like diabetes-related distress, socioeconomic status, and quality of life all influence how someone with type 2 diabetes actually fares over time.²² A person who is constantly stressed about their A1C, afraid to eat, and ashamed at every appointment may end up worse off than someone at the same A1C level who has a healthy relationship with the management process.

If you are at 7.4% and it is causing you significant anxiety, it is worth having a frank conversation with your care team about what your personal target should be and why. Understanding that 7.4% is, for many people, a reasonable number rather than a crisis can itself improve your quality of life and your willingness to stay engaged with treatment.

Factors That Shift Cardiovascular Risk Beyond Glucose

One of the clearest lessons from the past two decades of diabetes research is that glucose control is only one piece of cardiovascular protection. Research into how other risk factors modify the relationship between A1C and heart disease has shown that factors like blood pressure, lipid levels, smoking status, and existing vascular disease can amplify or diminish the cardiovascular harm of any given A1C level.²³ Two people with the same 7.4% A1C can have very different cardiac futures depending on whether those other factors are controlled.

This is why modern diabetes care rarely fixates on A1C in isolation. A comprehensive visit might spend as much time on your statin, your blood pressure medication, and your smoking cessation plan as it does on your glucose-lowering drugs. For someone at 7.4% who also has uncontrolled high blood pressure and elevated LDL cholesterol, addressing those two factors may do more to prevent a heart attack than shaving another half point off the A1C. Getting the whole picture right matters more than perfecting any single number.